Literature DB >> 23417661

Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.

Marko Zivcec1, David Safronetz, Dana Scott, Shelly Robertson, Hideki Ebihara, Heinz Feldmann.   

Abstract

Crimean-Congo hemorrhagic fever (CCHF) is a widely distributed viral hemorrhagic fever characterized by rapid onset of flu-like symptoms often followed by hemorrhagic manifestations. CCHF virus (CCHFV), a bunyavirus in the Nairovirus genus, is capable of infecting a wide range of mammalian hosts in nature but so far only causes disease in humans. Recently, immunocompromised mice have been reported as CCHF disease models, but detailed characterization is lacking. Here, we closely followed infection and disease progression in CCHFV-infected interferon α/β receptor knockout (IFNAR(-/-)) mice and age-matched wild-type (WT) mice. WT mice quickly clear CCHFV without developing any disease signs. In contrast, CCHFV infected IFNAR(-/-) mice develop an acute fulminant disease with high viral loads leading to organ pathology (liver and lymphoid tissues), marked proinflammatory host responses, severe thrombocytopenia, coagulopathy, and death. Disease progression closely mimics hallmarks of human CCHF disease, making IFNAR(-/-) mice an excellent choice to assess medical countermeasures.

Entities:  

Keywords:  CCHFV; coagulopathy; interferon α/β receptor knockout mice; pathology; proinflammatory response; thrombocytopenia

Mesh:

Substances:

Year:  2013        PMID: 23417661      PMCID: PMC3654741          DOI: 10.1093/infdis/jit061

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.

Authors:  Gurdal Yilmaz; Iftihar Koksal; Murat Topbas; Hulya Yilmaz; Firdevs Aksoy
Journal:  J Clin Virol       Date:  2010-02-09       Impact factor: 3.168

2.  Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality.

Authors:  P Onguru; S Dagdas; H Bodur; M Yilmaz; E Akinci; S Eren; G Ozet
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

3.  Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.

Authors:  Sándor Bereczky; Gunnel Lindegren; Helen Karlberg; Sara Akerström; Jonas Klingström; Ali Mirazimi
Journal:  J Gen Virol       Date:  2010-02-17       Impact factor: 3.891

4.  Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality.

Authors:  Mustafa A Cevik; Ayse Erbay; Hürrem Bodur; Evrim Gülderen; Aliye Baştuğ; Ayhan Kubar; Esragül Akinci
Journal:  Int J Infect Dis       Date:  2007-12-11       Impact factor: 3.623

5.  Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells.

Authors:  Christophe N Peyrefitte; Magali Perret; Stephan Garcia; Raquel Rodrigues; Audrey Bagnaud; Sandra Lacote; Jean-Marc Crance; Guy Vernet; Daniel Garin; Michèle Bouloy; Gláucia Paranhos-Baccalà
Journal:  J Gen Virol       Date:  2009-10-07       Impact factor: 3.891

6.  Crimean-Congo hemorrhagic fever in children.

Authors:  Hasan Tezer; Iclal Ayranci Sucakli; Tulin Revide Sayli; Elif Celikel; Ibrahim Yakut; Ateş Kara; Bahattin Tunc; Onder Ergonul
Journal:  J Clin Virol       Date:  2010-05-04       Impact factor: 3.168

7.  Viral load and Crimean-Congo hemorrhagic fever.

Authors:  Anna Papa; Christian Drosten; Silvia Bino; Evangelia Papadimitriou; Marcus Panning; Enkelejda Velo; Majlinda Kota; Arjan Harxhi; Antonis Antoniadis
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

8.  Viral load as predictor of Crimean-Congo hemorrhagic fever outcome.

Authors:  Darja Duh; Ana Saksida; Miroslav Petrovec; Salih Ahmeti; Iusuf Dedushaj; Marcus Panning; Christian Drosten; Tatjana Avsic-Zupanc
Journal:  Emerg Infect Dis       Date:  2007-11       Impact factor: 6.883

9.  Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses.

Authors:  Natalia Frias-Staheli; Nadia V Giannakopoulos; Marjolein Kikkert; Shannon L Taylor; Anne Bridgen; Jason Paragas; Juergen A Richt; Raymond R Rowland; Connie S Schmaljohn; Deborah J Lenschow; Eric J Snijder; Adolfo García-Sastre; Herbert Whiting Virgin
Journal:  Cell Host Microbe       Date:  2007-12-13       Impact factor: 21.023

Review 10.  Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis.

Authors:  Friedemann Weber; Ali Mirazimi
Journal:  Cytokine Growth Factor Rev       Date:  2008-11-21       Impact factor: 7.638

View more
  57 in total

Review 1.  The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 2: Vaccine efficacy studies.

Authors:  Marko Zivcec; Christina F Spiropoulou; Jessica R Spengler
Journal:  Antiviral Res       Date:  2020-01-22       Impact factor: 5.970

Review 2.  Recent advances in research on Crimean-Congo hemorrhagic fever.

Authors:  Anna Papa; Ali Mirazimi; Iftihar Köksal; Augustin Estrada-Pena; Heinz Feldmann
Journal:  J Clin Virol       Date:  2014-10-22       Impact factor: 3.168

Review 3.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

4.  Exploring Crimean-Congo Hemorrhagic Fever Virus-Induced Hepatic Injury Using Antibody-Mediated Type I Interferon Blockade in Mice.

Authors:  Michael E Lindquist; Xiankun Zeng; Louis A Altamura; Sharon P Daye; Korey L Delp; Candace Blancett; Kayla M Coffin; Jeffrey W Koehler; Susan Coyne; Charles J Shoemaker; Aura R Garrison; Joseph W Golden
Journal:  J Virol       Date:  2018-10-12       Impact factor: 5.103

5.  Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.

Authors:  David W Hawman; Kimberly Meade-White; Elaine Haddock; Rumi Habib; Dana Scott; Tina Thomas; Rebecca Rosenke; Heinz Feldmann
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

6.  Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus.

Authors:  Stephen R Welch; Florine E M Scholte; Mike Flint; Payel Chatterjee; Stuart T Nichol; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2017-10-09       Impact factor: 5.970

7.  Flipping the substrate preference of Hazara virus ovarian tumour domain protease through structure-based mutagenesis.

Authors:  John V Dzimianski; Savannah L Mace; Isabelle L Williams; Brendan T Freitas; Scott D Pegan
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-10-16       Impact factor: 7.652

8.  Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.

Authors:  Jeroen Kortekaas; Rianka P M Vloet; Alexander J McAuley; Xiaoli Shen; Berend Jan Bosch; Laura de Vries; Rob J M Moormann; Dennis A Bente
Journal:  Vector Borne Zoonotic Dis       Date:  2015-12       Impact factor: 2.133

9.  Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.

Authors:  Jessica R Spengler; Stephen R Welch; Florine E M Scholte; JoAnn D Coleman-McCray; Jessica R Harmon; Stuart T Nichol; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2019-08-01       Impact factor: 5.970

10.  The effect of inflammatory cytokines and the level of vitamin D on prognosis in Crimean-Congo hemorrhagic fever.

Authors:  Emine Parlak; Ayşe Ertürk; Yasemin Çağ; Engin Sebin; Musa Gümüşdere
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.